Spinocerebellar ataxia type 7: a neurodegenerative disorder with peripheral neuropathy. 2015

José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
Centro de Rehabilitación e Inclusión Social de Veracruz, Xalapa, Mexico.

BACKGROUND Autosomal dominant spinocerebellar ataxias (SCA) are a group of inherited neurodegenerative disorders that typically show peripheral neuropathy. SCA7 is one of the rarest forms of SCA (<1/100,000 individuals). However, the disease shows a prevalence of ∼800/100,000 inhabitants in certain regions of Mexico. This low global prevalence may explain, at least in part, the isolated anecdotal and limited clinical data regarding peripheral neuropathy in SCA7 patients. OBJECTIVE To assess sensory and motor peripheral nerve action potentials in an SCA7 patients group and in healthy volunteers, and subsequently correlate the electrophysiological findings with clinical and genetic features. METHODS We enrolled in our study, 13 symptomatic SCA7 patients with a confirmed molecular and clinical diagnosis, and 19 healthy volunteers as the control group. Nerve conduction studies were carried out using standard electromyography recording methods. The sensory and motor latency, amplitude and conduction velocity were recorded in both experimental groups and analyzed using the Student's t-test. RESULTS SCA7 patients showed a significant prolongation of sensory nerve conduction latencies, as well as a decrease in sensory amplitudes. Decreases in motor amplitudes and peroneal conduction velocity were also observed. Finally, we found an association between CAG repeats and the severity of cerebellar and non-cerebellar symptoms with electrophysiological signs of demyelinization. CONCLUSIONS Our results reveal the existence of a critical sensorimotor peripheral neuropathy in SCA7 patients. Moreover, we show that using sensitive electrophysiological tools to evaluate nerve conduction can improve the diagnosis and design of therapeutic options based on pharmacological and rehabilitative strategies. CONCLUSIONS These findings demonstrate that SCA7 is a disease that globally affects the peripheral nervous system.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009431 Neural Conduction The propagation of the NERVE IMPULSE along the nerve away from the site of an excitation stimulus. Nerve Conduction,Conduction, Nerve,Conduction, Neural,Conductions, Nerve,Conductions, Neural,Nerve Conductions,Neural Conductions
D010523 Peripheral Nervous System Diseases Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves. Peripheral Nerve Diseases,Peripheral Neuropathies,PNS (Peripheral Nervous System) Diseases,PNS Diseases,Peripheral Nervous System Disease,Peripheral Nervous System Disorders,Nerve Disease, Peripheral,Nerve Diseases, Peripheral,Neuropathy, Peripheral,PNS Disease,Peripheral Nerve Disease,Peripheral Neuropathy
D004576 Electromyography Recording of the changes in electric potential of muscle by means of surface or needle electrodes. Electromyogram,Surface Electromyography,Electromyograms,Electromyographies,Electromyographies, Surface,Electromyography, Surface,Surface Electromyographies
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
May 1998, Human molecular genetics,
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
January 2000, Ryoikibetsu shokogun shirizu,
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
October 2004, Archives of neurology,
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
January 2012, Handbook of clinical neurology,
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
January 2011, Jornal da Sociedade Brasileira de Fonoaudiologia,
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
March 2021, Brain pathology (Zurich, Switzerland),
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
November 2010, American journal of human genetics,
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
January 1999, Ryoikibetsu shokogun shirizu,
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
May 1988, Muscle & nerve,
José Salas-Vargas, and Jocelyn Mancera-Gervacio, and Luis Velázquez-Pérez, and Roberto Rodrígez-Labrada, and Emilio Martínez-Cruz, and Jonathan J Magaña, and Alfredo Durand-Rivera, and Oscar Hernández-Hernández, and Bulmaro Cisneros, and Rigoberto Gonzalez-Piña
April 2016, Cerebellum (London, England),
Copied contents to your clipboard!